knee OA
efficacy of autologous
Clinical trial of autologous adipose-derived mesenchymal stromal cells
autologous adult ASCs
single dose of autologous ASCs
large-scale clinical trial
randomized clinical trial
treatment of advanced OA
safety study
patients
knee degeneration
production of consistent batches of high-quality autologous ASCs
mesenchymal stem
cellular therapy
treatment of mild
centre Phase
samples of adipose tissue
phase IIb study
ADIPOA2
moderate osteoarthritis Osteoarthritis
definitive assessment of safety
cellular therapies
intraarticular injection
biologic therapy
abundance of tissue
absence of effective treatment options
multi-centre
injection of Hyaluronan
incurable disease
disease progression
high frequency of MSCs
culture
surgical intervention
pharmacological interference
ethical standards
GMP-compliant conditions
therapeutic approach
improvement
delivery
regenerative medicine
ACSs
subjects
month follow-up
sufficient statistical power
diseases
pain score
functional outcome
invasive harvest procedure
potential candidates
cell doses
adverse effects
highest contributor
lipoaspiration
EU consortium ADIPOA
global disability
large elements
man
purpose
project